📸 BIDMC Cancer Research Institute Associate Director Alex Toker is on the road FASEB #LSHSRC and is joined by event organizer Brooke Emerling Sanford Burnham Prebys. Dr. Toker is a featured speaker presenting on how PI3Ks influence metabolism #CancerResearch

According to the NCI, approx. 12k cases of soft tissue sarcoma and 3k cases of bone sarcoma are diagnosed yearly. Bone sarcomas are more common in children; soft tissue sarcomas are more common in adults. At BIDMC, we diagnose and treat these rare cancers #SarcomaAwarenessMonth

As we wrap up #SarcomaAwarenessMonth we encourage people to learn more about risk factors for this rare cancer type. At BIDMC, we are well-positioned to treat a wide range of sarcomas. Our tumor board meets weekly to discuss our most complex cases. We are committed to your care.

🫁 Today we recognize #WorldLungCancerDay - #LungCancer is the leading cause of cancer death in the US. Our thoracic oncology program has made great strides to improve screening options, develop novel therapies, and revolutionize care for our patients with lung cancer #lcsm

🫁 In honor of #WorldLungCancerDay: #CancerResearch spotlight Lung Cancer Journal: "Targeting of drug-tolerant persister cells (DTPs) as an approach to counter drug resistance in #NSCLC", Susumu Kobayashi and Thoracic Medical Oncology BIDMC⏩DTPs are key targets for overcoming drug resistance #lcsm

📰BIDMC investigators, led by Alissandra Hillis, PhD and advisor Alex Toker, found that combining statins, a common cholesterol medication, with AKT inhibitors kills triple negative #BreastCancer cells in preclinical models: bit.ly/3SDhPpT Cancer Research #CancerResearch #BCSM

We are pleased to share the 2023 BIDMC Nursing Annual Report. Please enjoy reading about the work of our extraordinary nurses. bit.ly/3WHEZg6

🫁#CancerResearch Spotlight: CDD press, BIDMC Department of Medicine, Thoracic Medical Oncology BIDMC and Susumu Kobayashi BIDMC Pathology⏩via spatial transcriptomics and single-cell RNA-seq, they found clinical evidence for targeting a protein, BCL-XL, to prevent drug resistance to EGFR inhibitors #lungcancer

David McDermott MD, Chief, Division of Medical Oncology BIDMC Department of Medicine shares what he enjoys about working BIDMC. "One reason I like being here is we treat everyone who comes to the hospital, the same standard of care, regardless of their circumstances." #MedTwitter

We're excited to announce the return of our in-person #yoga and #meditation workshop for patients with #cancer this September✨This workshop aims to provide participants with easy-to-use tools to practice yoga and mindful meditation at home. Sign up today: bit.ly/relax2restore

📰#CancerResearch Spotlight➡️Pourya Naderi and Winston hide BIDMC Pathology and others reveal how genes in tumors edit themselves to escape the immune system’s detection⏩this may be a common defense mechanism across various cancers: tinyurl.com/bdd9zp9j Nature Immunology #DNA #CancerResearch

#Yoga and #meditation can help patients with #cancer find emotional balance, reduce stress, improve energy, and reinvigorate feelings of joy and connection. Join us this September for our yoga workshop and learn helpful tips to feel restored and centered✨bit.ly/relax2restore

#CancerResearch Pourya Naderi Winston hide

🧬Join us this November for our 17th annual Cancer Center Symposium. Learn from prominent research and clinical leaders on emerging topics ranging from scientific discoveries, translational science, and healthcare delivery. Register now⏩ bit.ly/4dnBSAG #CancerResearch

#CancerResearch Spotlight: BIDMC investigators, Alissandra Hillis, PhD and advisor Alex Toker, found that combining statins, a common cholesterol medication, with AKT inhibitors kills triple negative #BreastCancer cells in preclinical models: bit.ly/3SDhPpT Cancer Research

🧬Hosted by BIDMC, Beth Israel Lahey Health, Dana-Farber and Mass General Brigham, this #cancer #genetics conference will cover topics relevant to people of all ages and gender identities, and allow time for Q&A with MDs and genetic counselors. ⏩bit.ly/3Z6C1Vh #BCSM

"We hope our work will create a new path forward to harness the power of the immune system to prevent relapse in patients with gastric #cancer," said Dr. Avigan BIDMC Department of Medicine

🧬Learn from prominent research and clinical leaders on emerging topics ranging from scientific discoveries, translational science, and healthcare delivery. ⏩bit.ly/4dnBSAG #CancerResearch

Join us next Saturday, 9/14 for an informative cancer genetics conference🧬Feat. Asaf Maoz and Michael Serzan, MD Dana-Farber to share best practices in #pancreaticcancer and #prostatecancer surveillance for those with BRCA 1/2 or PALB2 germline mutations. ⏩bit.ly/3Z6C1Vh

Our Cancer Research Institute Seminar Series is back in session! We are excited to host Aristotelis Tsirigos NYU GSOM Pathology next Thursday, 9/12 at 4 PM. His presentation will explore the potential of #AI in pathology and cancer diagnoses. #CancerResearch #PathTwitter #PrecisionMedicine